-transparent.png){kind=logo}
The synthesis of S-substituted derivatives of 1,4-benzoquinone-guanylhydrazone-thiosemicarbazone is described. The obtained 1,4-benzoquinone-guanylhydrazone-S-alkyl (resp. aralkyl)-isothiosemicarbazones, in comparison with the unsubstituted standard compound, showed a significantly decreased biological activity against the murine leukemias L 1210 and P 388 as well as against the growth of several kinds of bacteria. Therefore the S-substitution seems not to be useful for reaching a maximum activity.
Related Publications
W Schulze, and
W Gutsche, and
K Wohlrabe, and
W Fleck, and
D Tresselt
February 1983,
Die Pharmazie,
W Schulze, and
W Gutsche, and
K Wohlrabe, and
W Fleck, and
D Tresselt
January 1989,
Neoplasma,
W Schulze, and
W Gutsche, and
K Wohlrabe, and
W Fleck, and
D Tresselt
January 1983,
Dermatologische Monatschrift,
W Schulze, and
W Gutsche, and
K Wohlrabe, and
W Fleck, and
D Tresselt
January 1964,
Practica oto-rhino-laryngologica,
W Schulze, and
W Gutsche, and
K Wohlrabe, and
W Fleck, and
D Tresselt
February 1986,
Die Pharmazie,
W Schulze, and
W Gutsche, and
K Wohlrabe, and
W Fleck, and
D Tresselt
March 1980,
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
W Schulze, and
W Gutsche, and
K Wohlrabe, and
W Fleck, and
D Tresselt
February 2004,
The Journal of organic chemistry,
W Schulze, and
W Gutsche, and
K Wohlrabe, and
W Fleck, and
D Tresselt
September 1974,
Biochemical pharmacology,
W Schulze, and
W Gutsche, and
K Wohlrabe, and
W Fleck, and
D Tresselt
December 1995,
Yao xue xue bao = Acta pharmaceutica Sinica,
W Schulze, and
W Gutsche, and
K Wohlrabe, and
W Fleck, and
D Tresselt
January 1991,
Advances in experimental medicine and biology,
